These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25997534)

  • 1. Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.
    Cao Y; Pan R; Xuan W; Wei Y; Liu K; Zhou J; Wang W
    Org Biomol Chem; 2015 Jun; 13(24):6742-8. PubMed ID: 25997534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.
    Kuang Y; Balakrishnan K; Gandhi V; Peng X
    J Am Chem Soc; 2011 Dec; 133(48):19278-81. PubMed ID: 22035519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy.
    Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ
    Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen peroxide responsive theranostics for cancer-selective activation of DNA alkylators and real-time fluorescence monitoring in living cells.
    Saxon E; Ali T; Peng X
    Eur J Med Chem; 2024 Oct; 276():116695. PubMed ID: 39047609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time monitoring of drug release.
    Weinstain R; Segal E; Satchi-Fainaro R; Shabat D
    Chem Commun (Camb); 2010 Jan; 46(4):553-5. PubMed ID: 20062859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular theranostic prodrug based on a FRET-activated self-immolative linker.
    Redy O; Shabat D
    J Control Release; 2012 Dec; 164(3):276-82. PubMed ID: 22580227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders.
    Sufian A; Parihar N; Badirujjaman M; Barman P; Kesarwani R; Pemmaraju DB; Bhabak KP
    J Mater Chem B; 2024 May; 12(17):4248-4261. PubMed ID: 38602387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M; Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy.
    Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J
    Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
    Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
    ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.
    Ritschel WA; Ye W; Buhse L; Reepmeyer JC
    Int J Pharm; 2008 Oct; 362(1-2):67-73. PubMed ID: 18634862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
    Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
    J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
    Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
    Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds.
    Sinha S; Kumaran AP; Mishra D; Paira P
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5557-5561. PubMed ID: 27769619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
    Feng W; Gao C; Liu W; Ren H; Wang C; Ge K; Li S; Zhou G; Li H; Wang S; Jia G; Li Z; Zhang J
    Chem Commun (Camb); 2016 Aug; 52(60):9434-7. PubMed ID: 27379361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models.
    Lin M; Guo W; Zhang Z; Zhou Y; Chen J; Wang T; Zhong X; Lu Y; Yang Q; Wei Q; Han M; Xu D; Gao J
    Mol Pharm; 2020 Feb; 17(2):499-506. PubMed ID: 31825633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel caged DNA alkylating agents bearing 3,4-epoxypiperidine structure.
    Kawada Y; Kodama T; Miyashita K; Imanishi T; Obika S
    Org Biomol Chem; 2012 Jul; 10(26):5102-8. PubMed ID: 22614066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.